calculate the p/e ratio for Intuitive Surgical for years 2019-2023 information about the company.  what the p/e ratio is for each of the 5 years - 

                                                                                                                                                                                                                     

Report: Cash Flow
Type: Full Report
Company: Intuitive Surgical, Inc. (Cusip: 46120E602 Sic: 3842)
	2019	2020	2021	2022	2023
Operating CF
NET INCOME (LOSS)	1381.8	1066.8	1728.1	1344.4	1817.3
Depreciation and Amortization (CF)	216.1	293.3	332.2	392.4	454.8
Deferred Taxes	-8	57.6	-62.6	-185.3	-280.8
Stock-Based Compensation	335.8	395.4	449.2	513.2	592.8
Other Non-Cash Items	-6	-55.1	10.6	45.2	7.3
Total Non Cash Items	202.1	295.8	280.2	252.3	181.3
Change in Receivables	38.8	5.7	-142.3	-159.3	-186.3
Change in Inventories	-360.5	-170.1	-256	-546.6	-712.5
Change in Payables	12.3	-32.3	36	21.3	41.7
Change in Prepaid Expenses	-116.9	-111.8	-204.9	-129.2	24.2
Change in Accrued Liabilities	57.4	-16.6	115.1	51.5	34.8
Change in Deferred Revenues	35.5	15	32.6	21.5	53.4
Change in Other Assets & Liabilities	11.9	36.9	51.4	121.7	-32.9
Cash From OPERATING ACTIVITIES	1598.2	1484.8	2089.4	1490.8	1813.8
Investing CF
Capital Expenditure	-425.6	-341.5	-353.5	-532.4	-1064.2
Proceeds from Sales/Maturity of Investments	2677.1	3731.5	4352.7	3315.5	2920.4
Investment Purchased	-3346.2	-4292.9	-6452	-1399.5	-2207.4
Business Acquisition	-59.7	-37.7	-8.7	-12.8	-8.9
Cash From INVESTING ACTIVITIES	-1154.4	-940.6	-2461.5	1370.8	-360.1
Financing CF
Debt Reduction				-4.5	-2.9
Payments on Acquisition of Stock	-269.5	-134.3		-2607.4	-416.3
Proceeds from Sale of Stock	272.8	308.8	276.5	233.8	296.3
Other Financing CF	-171.7	-260.2	-233.5	-194.2	-164.7
Cash From FINANCING ACTIVITIES	-168.4	-85.7	43	-2572.3	-287.6
Effect of Exchange Rates	-2.2	-2.6	-3.4	5.4	3.3
NET CHANGE IN CASH & CASH EQUIVALENTS	273.2	455.9	-332.5	294.7	1169.4
Beginning Balance: Net Cash & Cash Equivalents	909.4	1182.6	1638.5	1306	1600.7
Ending Balance: Net Cash & Cash Equivalents	1182.6	1638.5	1306	1600.7	2770.1

 

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

Report: Balance Sheet
Type: Full Report
Company: Intuitive Surgical, Inc. (Cusip: 46120E602 Sic: 3842)
	2019	2020	2021	2022	2023	2024
Assets
Cash and Cash Items	1167.6	1622.6	1290.9	1581.2	2750.1
Marketable Securities	2054.1	3488.8	2913.1	2536.7	2473.1
Accounts Receivable	645.2	645.5	782.7	942.1	1130.2
Accounts & Notes Receivable	645.2	645.5	782.7	942.1	1130.2
Finished Goods	308.6	341.8	276.1		606
Work in Progress	75.9	75.6	96.4		159.9
Raw Materials	211	184.1	214.6		454.7				A/S = Ave
Total Inventories	595.5	601.5	587.1	893.2	1220.6				227.25%
Prepaid Expenses	200.2	267.5	271.1	299.8	314
TOTAL CURRENT ASSETS	4662.6	6625.9	5844.9	6253	7888				INCREASE IN ASSETS
Buildings	408.3	773.8	812.5		1002.1				2844.222
Land/Improvements	248	277.9	367.8		457.3
Machinery/Equipment	431.2	540.6	621.3		724.2
Construction in Progress	272.5	117.4	209.7		1354.7
Other PPE	476	625.3	833.7		1561.3
PPE at Cost	1836	2335	2845		5099.6
Accumulated Depreciation	-563.1	-757.7	-968.6		-1562
Property, Plant, and Equipment - Net	1272.9	1577.3	1876.4	2374.2	3537.6
Investments	2623.5	1757.7	4415.5	2623.6	2120
Goodwill	307.2	336.7	343.6	348.5	348.7
Intangible Assets	441.4	503.6	633.2	710.1	636.7
Goodwill & Intangibles	748.6	840.3	976.8	1058.6	985.4
Deferred Income Tax - Long Term	425.6	367.7	441.4	664.6	910.5
TOTAL ASSETS	9733.2	11168.9	13555	12974	15441.5	18285.72
Assets as % of SALES	217.33%	256.26%	237.39%	208.51%	216.75%
SALES	4478.5	4358.4	5710.1	6222.2	7124.1	8046.5849
Liabilities
Accounts Payable	123.5	81.6	121.2	147	188.7
Accounts and Notes Payable	123.5	81.6	121.2	147	188.7
Accrued Liabilities	568.9	533.3	651.4	877.8	1023.9
Deferred Revenues	337.8	350.3	377.2	397.3	446.1
TOTAL CURRENT LIABILITIES	1030.2	965.2	1149.8	1422.1	1658.7
Other Liabilities	418.3	444.6	453.7	439.3	385.5
TOTAL LIABILITIES	1427.6	1382.2	1553.1	1790.7	1954.5
Stockholders' Equity
Noncontrolling Interest	20.9	27.6	50.4	70.7	89.7
Common Stock	0.1	0.1	0.4	0.4	0.4
Additional Paid-In Capital	5756.8	6445.2	7164	7703.9	8576.4
Retained Earnings (Accumulated Deficit)	2494.5	3261.3	4760.9	3500.1	4743
Accumulated Other Comprehensive Income (Loss)	12.4	24.9	-24.2	-162.5	-12.2
TOTAL STOCKHOLDERS EQUITY	8284.7	9759.1	11951.5	11112.6	13397.3
TOTAL LIABILITIES AND EQUITY	9733.2	11168.9	13555	12974	15441.5

 

 

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

Report: Income Statements

 

Type: Full Report

Company: Intuitive Surgical, Inc. (Cusip: 46120E602 Sic: 3842)

ACTUALS - in $

FORECASTS

2019

2020

2021

2022

2023

2024

2025

Revenues

  Rev_Products

3754.3

3634.6

4793.9

5198

5956.3

  Rev_Services

724.2

723.8

916.2

1024.2

1167.8

 TOTAL REVENUE

4478.5

4358.4

5710.1

6222.2

7124.1

8046.584851

9088.520342

Expenses

   Services

249.2

266.9

287.5

325.9

352.8

   Product Sales

1119.1

1230.3

1464.1

1700.3

2041.8

  COGS

1368.3

1497.2

1751.6

2026.2

2394.6

2603.180883

2940.261347

  Research and Development

557.3

595.1

671

879

998.8

1062.08406

1199.61111

  Selling, General and Administrative

1178.4

1216.3

1466.5

1739.9

1963.9

2179.526028

2461.748308

 TOTAL COSTS AND EXPENSES

3104

3308.6

3889.1

4645.1

5357.3

5844.790972

6601.620765

 OPERATING INCOME (LOSS)

1374.5

1049.8

1821

1577.1

1766.8

2201.79388

2486.899577

  Interest Income

127.7

157.2

69.3

29.7

192.1

174.5412467

197.1422287

 EBITDA

1718.3

1500.3

2222.5

1999.2

2413.7

2860.143878

3230.497943

 EBIT

1502.2

1207

1890.3

1606.8

1958.9

2376.335126

2684.041806

 EBT

1502.2

1207

1890.3

1606.8

1958.9

2376.335126

2684.041806

  Income Tax Expense (Benefit)

120.4

140.2

162.2

262.4

141.6

240.6014979

271.7564841

 Income (Loss) Before Minority Interest

1381.8

1066.8

1728.1

1344.4

1817.3

2135.733628

2412.285322

  Non-controlling Interest (IS)

-2.5

-6.2

-23.5

-22.1

-19.3

-19.88663581

-22.46171481

 Income (Loss) Before Effects of Accounting Chg.

1379.3

1060.6

1704.6

1322.3

1798

2115.846993

2389.823607

 Income (Loss) Before Discontinued Operations

1379.3

1060.6

1704.6

1322.3

1798

2115.846993

2389.823607

 NET INCOME(LOSS)

1381.8

1066.8

1728.1

1344.4

1817.3

2135.733628

2412.285322

 NET INCOME COMMON SHAREHOLDERS

1379.3

1060.6

1704.6

1322.3

1798

Share Data

 Basic Shares

115.4

117

356.1

355.7

351.2

352.33

352.33

 Diluted Shares

119.5

120.3

365.8

362

357.4

 Basic EPS (Earnings Per Share or Earnings)

11.97

9.12

4.85

3.78

5.17

6.061742197

6.846664552

    

    

 Basic EPS Common Shares

11.95

9.06

4.79

3.72

5.12

 Diluted EPS

11.56

8.87

4.72

3.71

5.08

 Diluted EPS Common Shares

11.54

8.82

4.66

3.65

5.03

SALES GROWTH RATE

-2.68%

31.01%

8.97%

14.49%

12.95%

12.95%

ACTUALS - % of sales

2019

2020

2021

2022

2023

Hist. Ave

 TOTAL REVENUE

100.00%

100.00%

100.00%

100.00%

100.00%

100.00%

Expenses

   Services

5.56%

6.12%

5.03%

5.24%

4.95%

5.38%

   Product Sales

24.99%

28.23%

25.64%

27.33%

28.66%

26.97%

  COGS

30.55%

34.35%

30.68%

32.56%

33.61%

32.35%

  Research and Development

12.44%

13.65%

11.75%

14.13%

14.02%

13.20%

  Selling, General and Administrative

26.31%

27.91%

25.68%

27.96%

27.57%

27.09%

 TOTAL COSTS AND EXPENSES

69.31%

75.91%

68.11%

74.65%

75.20%

72.64%

 OPERATING INCOME (LOSS)

30.69%

24.09%

31.89%

25.35%

24.80%

27.36%

  Interest Income

2.85%

3.61%

1.21%

0.48%

2.70%

2.17%

 EBITDA

38.37%

34.42%

38.92%

32.13%

33.88%

35.54%

 EBIT

33.54%

27.69%

33.10%

25.82%

27.50%

29.53%

 EBT

33.54%

27.69%

33.10%

25.82%

27.50%

29.53%

  Income Tax Expense (Benefit)

2.69%

3.22%

2.84%

4.22%

1.99%

2.99%

 Income (Loss) Before Minority Interest

30.85%

24.48%

30.26%

21.61%

25.51%

26.54%

  Non-controlling Interest (IS)

-0.06%

-0.14%

-0.41%

-0.36%

-0.27%

-0.25%

 Income (Loss) Before Effects of Accounting Chg.

30.80%

24.33%

29.85%

21.25%

25.24%

26.29%

 Income (Loss) Before Discontinued Operations

30.80%

24.33%

29.85%

21.25%

25.24%

26.29%

 NET INCOME(LOSS)

30.85%

24.48%

30.26%

21.61%

25.51%

26.54%